Testing for sexually transmitted infections: A brave new world?

Sexually Transmitted Infections

Volumn 82, Issue 6, 2006, Pages 425-430

  Peeling, Rosanna W ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC TEST; EDITORIAL; GENITAL HERPES; GONORRHEA; HEALTH CARE COST; HEALTH PROGRAM; HEALTH SERVICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MALARIA; MEDICAL INFORMATION; MEDICOLEGAL ASPECT; NUCLEIC ACID AMPLIFICATION; PREGNANCY; PRENATAL MORTALITY; PREVALENCE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEXUALLY TRANSMITTED DISEASE; SYPHILIS; TRICHOMONAS VAGINALIS; TUBERCULOSIS; URINALYSIS; VAGINA DISCHARGE; VAGINA SMEAR;

FEMALE; HOME CARE SERVICES; HUMANS; INTERNET; MALE; NUCLEIC ACID AMPLIFICATION TECHNIQUES; POINT-OF-CARE SYSTEMS; SEXUALLY TRANSMITTED DISEASES; VAGINAL DISCHARGE;

EID: 33845869828     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.2005.017251     Document Type: Editorial

References (69)

1. Gaydos C, Dwyer K, Barnes M, et al. Internet-based screening for Chlamydia tractiomatis to reach nonclinic populations with mailed self-administered vaginal swabs. Sex Transm Dis 2006;33:451-7.
2. Shafer MA, Moncada J, Boyer CB, et al. Comparing first-void urine specimens, self-collected vaginal swabs, and endocervical specimens to detect Chlamydia trachomatis and Neisseria gonorrhoeae by a nucleic acid amplification test. J Clin Microbiol 2001;39:1008-16.
3. Boyadzhyan B, Yashida B, Yatabe H, et al. Comparison of the APTIMA CT and GC assays with the APTIMA COMBO 2 assay, the Abbott LCx assay, and direct fluorescent-antibody and culture assays for detection of Chlamydia trchomatis and Neisseria gonorrhoeae. J Clin Microbiol 2004;42:3089-93.
4. Van Der Pol B, Ferrero D, Buck-Barrington L, et al. Multicenter evaluation of the BDProbeTec ET system for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine specimens, female endocervical swabs, and male urethral swabs. J Clin Microbiol 2001;39:1008-16.
5. 5 Gaydos CA, Theodore M, Dalesio N, et al. Comparison of three nucleic acid amplification tests for detection of Chlamydia trachomatis in urine specimens. J Clin Microbiol 2004;42:3041-5.
6. 6 MacMillan S, McKenzie H, Flett G, et al. Feasibility of patient-collected vulval swabs for the diagnosis of Chlamydia trachomatis in a family planning clinic: a pilot study. Br J Fam Planning 2000;26:202-6.
7. Schachter J, Chernesky MA, Willis DE, et al. Vaginal swabs are the specimens of choice when screening for Chlamydia trachomatis and Neisseria gonorrhoeae: results from a multicenter evaluation of the APTIMA assays for both infections. Sex Transm Dis 2005;25:1851-3.
8. Gaydos CA, Rompalo AM. The use of urine and self-obtained vaginal swabs for the diagnosis of sexually transmitted diseases. Curr Infect Dis Rep 2002;4:148-57.
9. Wang LY, Burstein GR, Cohen DA. An economic evaluation of a school-based sexually transmitted disease screening program. Sex Transm Dis 2002;29:737-45.
10. Blake DR, Gaydos CA, Quinn TC. Cost-effectiveness analysis of screening adolescent males for Chlamydia on admission to detention. Sex Transm Dis 2004;31:85-95.
11. Kraut-Becher JR, Gift TL, Haddix AC, et al. Cost-effectiveness of universal screening for chlamydia and gonorrhea in US jails. J Urban Health 2004;81:453-71.
12. Arcari CA, Gaydos JC, Howell MR, et al. Feasibility and short-term impact of linked education and urine screening interventions for Chlamydia and Gonorrhea in male army recruits. Sex Transm Dis 2004;31:443-7.
13. Aledort JE, Hook EW III, Weinstein MC, et al. The cost effectiveness of gonorrhea screening in urban emergency departments. Sex Transm Dis 2005;32:425-36.
14. Novak DP, Lindholm L, Jonsson M, et al. A Swedish cost-effectiveness analysis of community-based Chlamydia trachomatis PCR testing of postal urine specimens obtained at home. Scand J Public Health 2004;32:324-32.
15. van Valkengoed IG, Postma MJ, Morre SA, et al. Cost effectiveness analysis of a population based screening programme for asymptomatic Chlamydia trachomatis infections in women by means of home obtained urine specimens. Sex Transm Infect 2001;77:276-82.
16. Salisbury C, Macleod J, Egger M, et al. Opportunistic and systematic screening for chlamydia: a study of consultations by young adults in general practice. Br J Gen Pract 2006;56:99-103.
17. van Bergen JE, Postma MJ, Peerbooms PG, et al. Effectiveness and cost-effectiveness of a pharmacy-based screening programme for Chlamydia trachomatis in a high-risk health centre population in Amsterdam using mailed home-collected urine samples. Int J STD AIDS 2004;15:797-802.
18. Adams EJ, Garcia PJ, Garnett GP, et al. The cost-effectiveness of syndromic management in pharmacies in Lima, Peru. Sex Trans Dis 2003;30:379-87.
19. Levine DK, Scott KC, Klausner JD. Online syphilis testing-confidential and convenient. Sex Transm Dis 2005;32:139- 41.
20. Mabey D, Peeling RW, Perkins MD. Rapid and simple point-of-care diagnostics for STIs. Sex Transm Infect 2001;77:397-8.
21. Mabey D, Peeling RW. Rapid diagnostics tests for sexually transmitted infections. Int Plann Parent Fed Med Bull 2002;36:1-3.
22. Gaydos CA. Rapid tests for sexually transmitted diseases. Curr Infect Dis Rep 2006;8:115-24.
23. Gift TL, Pate MS, Hook EW, et al. The rapid test paradox: when fewer cases detected led to more cases treated. Sex Transm Dis 1999;26:232-40.
24. Mukenge L, Alary M, Lowndes CM, et al. Syndromic versus laboratory-based diagnosis of cervical infections among female sex workers in Benin: implications of non-attendance for return visits. Sex Transm Dis 2002;29:324-30.
25. Vickerman P, Peeling RW, Watts C. Detection of gonococcal infection: pros and cons of a rapid test. Mol Diagn 2005;9:175-9.
26. Suzuki K, Matsumoto T, Murakami H, et al. Evaluation of a rapid antigen detection test for Neisseria gonorrhoeae in urine sediment for diagnosis of gonococcal urethritis in males. J Infect Chemother 2004;10:208-11.
27. Woolley PO, Pumphrey J. Application of 'Clearview Chlamydia' for the rapid detection of cervical chlamydial antigen. Inf J STD AIDS 1997;8:257-8.
28. Widjaja S, Cohen S, Brady WE, et al. Evaluation of a rapid assay for detection of Chlamydia trachomatis infections in outpatient clinics in South Kalimantan, Indonesia. J Clin Microbiol 1999;37:4183-5.
29. Pate MS, Dixon PB, Hardy K, et al. Evaluation of the Biostar Chlamydia OIA assay with specimens from women attending a sexually transmitted disease clinic. J Clin Microbiol 1998;36:2183-6.
30. Alary M, Aina G, Ndour M, et al. Evaluation of the PATH GC-Check rapid test for the detection of gonococcal infection among female sex workers in Benin. Sex Transm Infect 2006: In press.
31. Benzaken AS, Galban ES, Antures W, et al. The diagnosis of gonococcal infection in high risk women using rapid test. Sex Transm Infect 2006. Published Online First: 21 November 2006. doi: 10.1136/sti.2006.022566.
32. Yin YP. Evaluation of the clearview chlamydia rapid test in China. Sex Transm Infect 2006. Published Online First: 22 November 2006. doi: 10.1136/sti.2006.022475.
33. World Health Organization. Guidelines for the management of sexually transmitted infections. WHO/HIV_AIDS/2001.01. Geneva: WHO, 2001.
34. Hawkes S, Morison L, Foster S, et al. Reproductive-tract infections in women in low-income, low-prevalence situations: assessment of syndromic management in Matlab, Bangladesh. Lancet 1999;354:1776- 81.
35. Pepin J, Deslandes S, Khonde N, et al. Low prevalence of cervical infections in women with vaginal discharge in west Africa: implications for syndromic management. Sex Transm Infect 2004;80:230.
36. Amsel R, Totten PA, Spiegel CA, et al. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic association. Am J Med 1983;74:14-22.
37. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis improved by a standardized method of Gram stain interpretation. J Clin Microbiol 1991;29:297-301.
38. Myziuk L, Romanowski B, Johnson SC. BVBlue test for diagnosis of bacterial vaginosis. J Clin Microbiol 2003;41:1925-8.
39. Bradshow CS, Morton AN, Garland SM, et al. Evaluation of a point-of-care test, BVBlue, and clinical and laboratory criteria for diagnosis of bacterial vaginosis. J Clin Microbiol 2005;43:1304-8.
40. Wiggins R, Crowley T, Horner PJ, et al. Use of 5-bromo-4-chloro-3-indoyl-a-D-N-acetylneuraminic acid in a novel spot test to identify sialidase activity in vaginal swabs from women with bacterial vaginosis. J Clin Microbiol 2000;38:3096-7.
41. West B, Morrison L, Van Der Leoff MS, et al. Evaluation of a new rapid diagnostic kit (FemExam) for bacterial vaginosis in patients with vaginal discharge syndrome in The Gambin. Sex Transm Dis 2003;30:483-9.
42. Hay P, Tummom A, Ogunfile M, et al. Evaluation of a novel diagnostic test for bacterial vaginosis: 'the electronic nose'. Int J STD AIDS 2003;14:114-18.
43. Huppert JS, Batteiger BE, Braslins P, et al. Use of an immunochromatographic assay for rapid detection of Trichomonas vaginalis in vaginal specimens. J Clin Microbiol 2005;43:684-7.
44. World Health Organization. Global prevalence ana incidence of selected curable sexually transmitted infections: overview and estimates, WHO/HIV_AIDS/2001.02. Geneva: WHO, 2001.
45. Tichonovo L, Borisenko K, Ward H, et al. Epidemics of syphilis in the Russian Federation: trends, origins, and priorities for control. Lancet 1997;350:210-13.
46. Lin C, Gao X, Chen XS, et al. China's syphilis epidemic: a systematic review of seroprevalence studies. Sex Transm Dis 2006;33 Published Online first 31 May 2006.
47. Marra CM, Holmes KK. Update on syphilis: resurgence of an old problem. JAMA 2003;290:1510-14.
48. Van Dyck, Maheus A, Piot P. Laboratory diagnosis of sexually transmitted diseases. Geneva: World Health Organization, 1990.
49. Peeling RW, Ye H. Diagnostic tools for preventing and managing maternal and congenital syphilis: an overview. Bull World Health Organ 2004;82:439-46.
50. West B, Walraven G, Morison L, et al. Performance of the rapid plasma_reagin and the rapid syphilis screening tests in the diagnosis of syphilis in field conditions in rural Africa. Sex Transm Infect 2002;78:282-5.
51. Diaz T, Almeida MG, Georg I, et al. Evaluation of the Determine Rapid Syphilis TP Assay using sera. Clin Diagn Lab Immun 2004;11:98-101
52. Fears MB, Pope V. Syphilis Fast Latex agglutination test, a rapid confirmatory test. Clin Diagn Lab Immunol 2001;8:841-2.
53. Siedner M, Zapitz V, Ishida M, et al. Performance of rapid syphilis tests in venous and whole blood specimens. Sex Transm Dis 2004;31:557-60.
54. UNICEF/UNDP/World Bank/WHO. Special Program for Research and Training in Tropical Diseases, World Health Organization. Sexually Transmitted Diseases Diagnostics Initiative Report Diagnostics Evaluation Series number 1. 2003. http://www.who.int/std_diagnostics/publications/meetings/SDI_Report.pdf.
55. Lien TX, Tien NT, Chanpong GF, et al. Evaluation of rapid diagnostic tests for the detection of human immunodeficiency virus types 1 and 2 hepatitis B surface antigen, and syphilis in Ho Chi Minh City, Vietnam. Am J Trop Med Hyg 2000;62:301-9.
56. Montoya PJ, Lukehart SA, Brentlinger PE, et al. Comparison of the diagnostic accuracy of a rapid immunochromatographic test and the rapid plasma regain test for antenatal syphilis screening in Mozambique. Bull World Health Organ 2006;84:97-104.
57. Herring AY, Ballard RC, Pope V, et al. A multi-centre evaluation of nine rapid, point of care syphilis tests using archived sera. Sex Transm Infect 2006. Published Online First: 21 November 2006. doi: 10.1136/sti.2006.022707
58. Mabey D, Peeling RW, Ballard RC, et al. Prospective, multi-centre clinic-based evaluation of four rapid diagnostic tests for syphilis. Sex Trams Infect 2006. Published Online First: 22 November 2006. doi: 10.1136/sti.2006.022467.
59. Gloyd S, Chai S, Mercer MA. Antenatal syphilis in sub-Saharan Africa: missed opportunities for mortality reduction. Health Policy Plan 2001;16:29-34.
60. Watson-Jones D, Changalucha J, Gumodoka B, et al. Syphilis and pregnancy outcomes in Tanzania. 1. Impact of maternal syphilis on outcome of pregnancy in Mwanza Region, Tanzania. J Infect Dis 2002;186:940- 7.
61. Schmid G. Economic and programmatic aspects of congenital syphilis prevention. Bull World Health Organ 2004;82:402-9.
62. Southwick KL, Blanco S, Santander A, et al. Maternal and congenital syphilis in Bolivia, 1996: prevalence and risk factors. Bull World Health Organ 2001;79:33-42.
63. Ashley RL, Wald A, Eagleton M. Premarket evaluation of the POCkit HSV-2 type-specific serologic test in culture-documented cases of genital herpes simplex virus type 2. Sex Transm Dis 2000;27:266-9.
64. Vickermon P, Watts C, Alary M, et al. Sensitivity requirements for the point of care diagnosis of Chlamydia trachomatis and Neisseria gonorrhoeae. Sex Transm infect 2003;79:363-7.
65. World Health Organization Diagnosis for tuberculosis: global demand and market potential. Annex: Regulation of in vitro diagnosis: a global perspective, 194-203.
66. Peeling RW, Smith PJ, Bossuyt PMM. A guide for diagnostic evaluations. Nat Microbiol Rev 2006;S2-6, http://www.nature.com/nrmicro/ supplements (accessed 25 Oct 2006), (Suppl).
67. McFarlane M, Bull S, Rietmeijer CA. The internet as a newly emerging risk environment for sexually transmitted diseases. JAMA 2000;284:443-6.
68. McFarlane M, Kachur R, Bull S, et al. Women, the internet, and sexually transmitted infections. Women's Health (Larchmt) 2004;13:689-94.
69. McFarlane M, Kachur R, Klausner JD, et al. Internet-based health promotion and disease central in the 8 cities: successes, barriers, and future plans. Sex Transm Dis 2005;32:S60-4.